Professor Calman MacLennan, Senior Program Officer, Bacterial Vaccines, Global Health - Enteric & Diarrheal Diseases, Bill & Melinda Gates Foundation, USA, Senior Clinical Fellow, Jenner Institute, University of Oxford, UK, Director, BactiVac Bacterial Vaccinology Network & Professor of Vaccine Immunology, University of Birmingham, UK

Developing Assays and Standards to Support Shigella Vaccine Development

Robert Choy, PhD, Director of Research & Development @PATH

MEEDAT, a Multiplex ELISA of Biomarkers for Environmental Enteric Dysfunction

Coryandar (Cory) Gilvary, PhD, Chief Data Scientist & Co-Founder @ OneThree Biotech

AI Approach for Identifying Drug Sensitivity Biomarkers Across Diverse Data Types for Patient Selection

Erica Troksa, PhD, Associate Director, Translational Biomarker Solutions & Global Immunology @ Covance

COVID-19 Rapid Response Biomarker Implementation

James Rudge, PhD, Technical Director @ Neoteryx

"Using Remote Sampling to Analyze Biomarkers - Benefits and Challenges" 

Chuck Drucker, PhD, Head of Decentralized Trial Solutions @ Q2 Solutions

The Impact of Decentralized Clinical Trials on Laboratory Testing

Self-collection of blood samples and at home point of care testing in clinical trials

Francis Jones, PhD, Senior Director, DCT/Digital Strategy and Innovation @PPD

Decentralized Clinical Trials - The Bigger Picture

Kelly Dong, PhD, CEO UP Pharma, Shanghai, China

Current Practice and Perspectives for Biomarker Analysis in China

Zhanmin Lin, PhD,  Teddy Lab

Driving Biomarker Research in China

Christopher Kirkham, PhD, Manager Bioanalytical Services Group @ Charles River Laboratories

Translating Pharmacodynamic Immune Biomarkers to the Clinic